Wall Street Wildlife Investing Podcast

The largest UK fintech is abandoning the London Stock Exchange for the NASDAQ — and Luke thinks it could be an inflection point. This solo deep-dive makes the bull AND bear case on one of his highest-conviction holdings, right before the dual listing goes live. Here's what every investor needs to know before May 11th.
💰 Why $WISE is ditching London for the NASDAQ — and what it means for shareholders who already own the UK listing
📊 The numbers behind the conviction: 27% volume growth, 22% more active customers, and a take rate that keeps falling on purpose
🎓 How Wise actually moves money across borders — the elegant infrastructure trick that lets them undercut every bank on the planet
🎯 Luke's reverse DCF breakdown: what growth rate the market is currently pricing in, and whether that's a gift or a trap
💀 The bear case we can't hide from: falling take rates + rising costs = a business model that only works if volume growth never stops
🤖 Stablecoins and the Genius Act — is crypto a real existential threat to $WISE, or just a question every investor asks and never acts on?
🌐 The index inclusion catalyst: why Russell 1000 membership in 2027 could trigger a wave of institutional buying nobody's talking about yet

Sources:
Shooting the Bull with Drowsy and Bear: https://open.spotify.com/show/5qH1zzezA4EnHHGibgzJlb?si=XkN43t9ZRUuAD8Mh2RMvzg&nd=1&dlsi=a7c955266e91477f

Segments:
00:00:00 Welcome — Solo Episode & What's Coming to WSW
00:01:21 What Is Wise and How Does It Actually Work?
00:04:08 The NASDAQ Dual Listing: Dates, Mechanics & What Shareholders Need to Do
00:09:05 $WISE Key Numbers: Volume Growth, Customers & Take Rate
00:11:08 Rising Costs: Investment in Growth or a Warning Sign?
00:12:44 $WISE Valuation: Reverse DCF & The Inflection Point Thesis
00:14:54 Bear Case #1: The Take Rate Trap
00:15:48 Bear Case #2: Stablecoins & Crypto — Real Threat or Overhyped?
00:18:11 Luke's Conviction: 4 Years as Customer & Shareholder

**********
If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠
**********
SUPPORT THE SHOW AND BECOME A PATREON:
wallstreetwildlife.com
**********
Follow us at:
⁠⁠x.com/7LukeHallard
⁠x.com/7FlyingPlatypus
**********
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.
Get 15% off any premium plan with:
fiscal.ai/wildlife
**********
Monkey’s “Zen, Nietzsche, How to Live” Substack:
firephilosophy.substack.com
**********
To use the same portfolio tracking tool as Luke, check-out:
portseido.com/?fpr=lukehallard
**********
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
**********
Fed up with the stock market giving you a hard time?
- Invest like seasoned pros with over 40 years in the game
- Discover the world's leading companies
- Sharpen your best investing practices and ditch the worst
- Learn how to start investing
- Essential investing principles to boost your returns

Keywords:
$WISE, Wise PLC, NASDAQ dual listing, fintech investing, cross-border payments, stablecoins, Genius Act, take rate, reverse DCF, index inclusion, Russell 1000, Wise platform, fintech stock, London Stock Exchange, UK fintech, free cash flow, institutional buying, crypto vs fintech, position sizing, high conviction investing, compounding moat, growth investing, Luke Hallard, Wall Street Wildlife

Luke sold two stocks this week. Not because earnings disappointed or guidance missed — but because he ran the numbers on what AI actually does to software valuations, and the math got uncomfortable fast. Meanwhile, Krzysztof turned a 70% options loss into a breakeven exit... then watched the stock moon another 60%... then crater 50% — all in the same week. This is what investing in the AI era actually feels like.
💀 Monkey's $POET call option went from genius to idiot to genius in 7 days — a masterclass in what NOT to do with options, and the one trading rule that could have saved him
🎓 Badger breaks down the DCF concept most investors ignore: why a 5% annual "AI death probability" can slash a company's fair value by nearly 50% — and why that math should terrify SaaS investors
🤖 "It's not that AI will build a better ServiceNow — it's that you won't NEED ServiceNow" — the Kodak fallacy hiding in plain sight across your portfolio
🎯 Luke sold $CRM and $ZS this week — hear exactly why, and whether $CRWD is next on the chopping block
🧠 The ostrich investor, anchoring bias, and why knowing what can go wrong is the most valuable skill in your arsenal right now
🌴 Community portfolio 6-month check-in: $WISE up 23%, the overall portfolio down 12% — and why that's not the point

Sources:
King of the Jungle Spreadsheet: https://www.patreon.com/posts/150190962
The Investor's Mirror (iOS App): https://apps.apple.com/us/app/investors-mirror/id6760048070

Segments:
00:00:00 Cold Open: AI Is Killing Companies — Not Replacing Them
00:00:54 Intro + Luke Bought a Motorcycle (Investing Adjacent, We Promise)
00:10:57 Monkey's $POET Options Debacle: From 70% Loss to Breakeven to... 50% Drop
00:21:43 The SaaS Apocalypse: How AI Rewrites Software Valuations
00:33:39 Why ServiceNow Might Not Need a Replacement — It Just Disappears
00:41:34 Luke Sold $CRM and $ZS — Here's the Exact Reasoning
00:54:52 Is $CRWD Next? The CrowdStrike Question
00:57:32 Community Portfolio 6-Month Review: $WISE, $TTD, and What's Next

**********
If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠
**********
SUPPORT THE SHOW AND BECOME A PATREON:
wallstreetwildlife.com
**********
Follow us at:
⁠⁠x.com/7LukeHallard
⁠x.com/7FlyingPlatypus
**********
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.
Get 15% off any premium plan with:
fiscal.ai/wildlife
**********
Monkey’s “Zen, Nietzsche, How to Live” Substack:
firephilosophy.substack.com
**********
To use the same portfolio tracking tool as Luke, check-out:
portseido.com/?fpr=lukehallard
**********
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
**********
Fed up with the stock market giving you a hard time?
- Invest like seasoned pros with over 40 years in the game
- Discover the world's leading companies
- Sharpen your best investing practices and ditch the worst
- Learn how to start investing
- Essential investing principles to boost your returns

Keywords:
$POET,$CRM,$ZS,$CRWD,$WISE,$TTD,SaaS apocalypse,AI disruption stocks,software valuation,DCF terminal value,options trading mistakes,AI death probability,ServiceNow AI risk,Salesforce disruption,Zscaler analysis,CrowdStrike AI,community portfolio,position sizing,anchoring bias,options psychology,retail investor mistakes,Kelly Criterion,compounder investing,growth stocks 2025,AI investing,$NU,$IREN,$NOW

200 million eczema sufferers. A leading drug that fails more than half of them. A cancer-causing alternative that still projects $5 billion in sales. And a tiny 60-person San Francisco biotech that may have cracked the code — with a Nobel Prize-validated mechanism the market is somehow pricing at near-zero. This week, Krzysztof goes full deep-dive on Nectar Therapeutics ($NKTR), while Luke — self-confessed biotech skeptic — has the options chain open and his wallet ready.📊 Why the world's most common skin disease has NO good cure yet — and why that $50B market opportunity is hiding in plain sight💊 The cancer-warning drug that still projects $3–5B in revenue: what that tells you about how desperate patients really are🎓 Res-peg explained without the jargon: the Nobel Prize-backed immune reset mechanism that makes $NKTR different from every other AD drug on the market💀 The 33% single-day crash that Monkey calls 'borderline irrational' — and why buying that dip may have been one of the most logical trades of the year🎯 Bull, base, and bear: a $240–$320 price target vs. today's ~$82 — and the position sizing rules that keep this from becoming a gamble🧠 Why the market can't walk and chew gum: how $NKTR's alopecia data confusion is creating a 'free call option' that most investors are completely missing🌐 The imminent April catalyst that could reprice this stock overnight — and why Monkey says a negative surprise would be the real shockSources:Adam May (biotech investor): https://x.com/A_May_MDSegments:00:00:00 The Disease Affecting 200 Million People With No Real Cure00:05:00 What Is Atopic Dermatitis (Eczema) — And Why It's a $50B Market00:10:00 Why the Best Drug on the Market Only Works for Half of Patients00:15:00 The Cancer-Warning Drug Still Projecting $5B in Sales00:20:00 $NKTR's Res-Peg: The Nobel Prize-Backed Mechanism Explained00:27:00 The Phase 2 Data That Sent $NKTR From $6 to $8000:33:00 The Alopecia Trial Disaster — And Why Monkey Says the Market Overreacted00:43:00 Valuation Deep Dive: Is $NKTR Worth 4x From Here?00:48:00 Upcoming Catalysts: What to Watch in April 2025 and Beyond00:54:00 Position Sizing in Biotech — How Much Is Too Much?01:01:00 Options Strategy for $NKTR: Calls vs. Shares vs. Selling Puts
**********
If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠
**********
SUPPORT THE SHOW AND BECOME A PATREON:
wallstreetwildlife.com
**********
Follow us at:
⁠⁠x.com/7LukeHallard
⁠x.com/7FlyingPlatypus
**********
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.
Get 15% off any premium plan with:
fiscal.ai/wildlife
**********
Monkey’s “Zen, Nietzsche, How to Live” Substack:
firephilosophy.substack.com
**********
To use the same portfolio tracking tool as Luke, check-out:
portseido.com/?fpr=lukehallard
**********
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
**********
Fed up with the stock market giving you a hard time?
- Invest like seasoned pros with over 40 years in the game
- Discover the world's leading companies
- Sharpen your best investing practices and ditch the worst
- Learn how to start investing
- Essential investing principles to boost your returns

Keywords:
$NKTR, Nectar Therapeutics, atopic dermatitis, eczema investing, biotech stock 2025, res-peg, alopecia treatment, biotech options strategy, small cap biotech, phase 2 clinical trial, biotech position sizing, $KYMR, Dupixent competitor, JAK inhibitors, T regulatory cells, biotech catalyst, Wall Street Wildlife, undervalued biotech, options implied volatility, Kelly Criterion biotech, free call option, clinical trial design, immune system investing, rezpegaldesleukin

The AI arms race is here, and it's shaking up the cybersecurity landscape. Is it time to panic, or is this a buying opportunity? We dive deep into the AI doomsday fears and how it could impact our portfolios.

Plus:
🧠 Axon's stock-based comp problem: a great company, TERRIBLE stock? $AXON
📊 Wise's Nasdaq listing is imminent: what does it mean for investors? $WISE $WIZEY
💊 Krzysztof's selling Coherus for a NEW biotech play: $CHRS $NKTR $ABCL

Segments:
00:00:00 Cold Open
00:01:47 Subscriber Growth Slowdown: Are We Boring?
00:03:57 Mama Monkey's Patreon Offer
00:05:51 Claude Mythos & Cybersecurity Apocalypse?
00:11:06 Is AI a Tailwind or Headwind for Cybersecurity Stocks?
00:11:46 $CRWD CrowdStrike: Time to Buy?
00:22:26 $NKTR Nectar Therapeutics: Krzysztof's New Biotech Pick
00:28:05 $AXON Axon Enterprise: Great Company, Terrible Stock?
00:30:52 Stock-Based Compensation Explained
00:42:37 $WISE Wise PLC: Nasdaq Listing Incoming!
00:45:19 Investor's Mirror App Update
00:50:54 Closing
**********
If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠
**********
SUPPORT THE SHOW AND BECOME A PATREON:
wallstreetwildlife.com
**********
Follow us at:
⁠⁠x.com/7LukeHallard
⁠x.com/7FlyingPlatypus
**********
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.
Get 15% off any premium plan with:
fiscal.ai/wildlife
**********
Monkey’s “Zen, Nietzsche, How to Live” Substack:
firephilosophy.substack.com
**********
To use the same portfolio tracking tool as Luke, check-out:
portseido.com/?fpr=lukehallard
**********
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
**********
Fed up with the stock market giving you a hard time?
- Invest like seasoned pros with over 40 years in the game
- Discover the world's leading companies
- Sharpen your best investing practices and ditch the worst
- Learn how to start investing
- Essential investing principles to boost your returns

Keywords:
artificial intelligence, cybersecurity, $CRWD, CrowdStrike, $PANW, Palo Alto Networks, $WISE, Wise PLC, fintech, stock-based compensation, investing psychology, portfolio allocation, biotech, $NKTR, Nectar Therapeutics, value investing, growth investing, investor's mirror, fiscal ai, $ABCL

Are hidden emotions sabotaging your investing returns? This week, Badger and Monkey dissect the subtle ways 'tilt' impacts portfolios, drawing lessons from Vegas, poker, and real-life market turmoil. Are YOU making these mistakes without realizing it?

💀 Are your losses secretly driving your investment decisions? We expose the hidden dangers of revenge trading.
🎰 Vegas isn't just about luck. Discover the surprising parallels between poker, investing, and crafting your own odds.
🧠 Is your 'investor self' different from your REAL self? We explore the psychology behind knowing what to do vs. actually doing it (try our 'Investor's Mirror' app)
📊 Are you tuning out during market downturns? Learn why now is the time to sharpen your skills and find big alpha.
🌴 From Vegas to Warsaw? We reveal our plans for a European WSW Beastie meetup in 2027!
🌐 Should you invest outside the US? We debate the pros and cons of international diversification.
🤖 The future of shopping is HERE. We discuss Amazon's robotaxis, automated warehouses, and the evolution of retail.

Sources:
The Investor's Mirror (iOS App): https://apps.apple.com/us/app/investors-mirror/id6760048070
ADRs article: https://7investing.com/article/how-to-invest-internationally-using-american-depositary-receipts-alternative-title-the-abcs-of-adrs/

Segments:
00:00:00 Intro: Vegas Recap & Investor Tilt
00:03:27 The Vegas Glow-Up: IRL vs. Digital
00:06:45 Krzysztof's Near-Tilt Experience
00:11:55 Tilt in Poker vs. Investing
00:14:05 The Subtle Tilt Investors Don't See
00:17:51 Carving Out Your Safe Space (Even in Vegas)
00:23:14 The King of the Jungle Poker Challenge
00:31:46 Practicing Fear: Lessons from Poker
00:32:17 Vegas Tech Tour: Amazon & The Boring Company
00:39:13 Zoox Robo Taxi: The Future of Transportation
00:42:06 The Sphere: Gimmick or Game-Changer? $SPHR
00:46:26 Absinthe: A Night to Remember
00:48:16 WSW Does Warsaw: Summer 2027?
00:50:52 Introducing the Investor's Mirror App
01:02:02 Investing Outside the US: Opportunities & Risks

**********
SUPPORT THE SHOW AND BECOME A PATREON:
wallstreetwildlife.com
**********
Follow us at:
⁠⁠x.com/7LukeHallard
⁠x.com/7FlyingPlatypus
**********
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.
Get 15% off any premium plan with:
fiscal.ai/wildlife
**********
Monkey’s “Zen, Nietzsche, How to Live” Substack:
firephilosophy.substack.com
**********
To use the same portfolio tracking tool as Luke, check-out:
portseido.com/?fpr=lukehallard
**********
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
**********
Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game
- Discover the world's leading companies
- Sharpen your best investing practices and ditch the worst
- Learn how to start investing
- Essential investing principles to boost your returns